Scientists uncover a better way to kill cancer cells
A new paper published in Molecular Cell by senior author Dr. David Andrews suggests a new approach to chemotherapy drugs that may be more effective than current methods. The research shows a new way to target “guardian proteins” that slow down programmed cell death, using switch-like activation by allosteric inhibitors. Read more of the story here.
Read MorePersonalizing cancer therapy through imaging: A look inside the Andrews lab
The video above is a look inside Andrews lab, where scientists are using advanced imaging, robots and artificial intelligence to monitor how cancer cells respond to various treatment combinations. This information can be used to guide studies in precision medicine to develop optimal drug combinations tailored to individual cancer patients. Read more of the story...
Read MoreAn incubator of medical innovation
Dr. David Andrews, director of Biological Sciences at SRI, was interviewed by The Globe and Mail about the state of the art Opera FLIM system which was developed at the DWA lab in collaboration with the industry. Please click here for a pdf of the article. Photo: Tim Fraser http://www.theglobeandmail.com/life/health-and-fitness/advsunnybrook/healing-the-future/an-incubator-of-medical-innovation/article13116883/
Read MoreSeeing Things
Dr. David Andrews, director of Biological Sciences at SRI, was awarded a Leading Edge Fund grant from the Canada Foundation for Innovation worth $2,469,665. Please click here for the complete article.
Read More
Find David Andrews Lab Plasmids